Nexalin Technology (NXL) Receivables (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Receivables of $43004.0 for Q1 2026, down 58.57% year-over-year from $103809.0 in Q1 2025, and down 47.28% quarter-over-quarter from $81571.0 in Q4 2025.
Nexalin Technology (NXL) Receivables (2021 - 2026) Analysis & Trends
Nexalin Technology's Receivables history runs 6 years deep, the most recent figure standing at $43004.0 for Q1 2026.
- In Q1 2026, Receivables fell 58.57% year-over-year to $43004.0; the TTM figure through Mar 2026 stood at $43004.0 (down 58.57% YoY), while the FY2025 annual figure was $81571.0, down 20.32% from the prior year.
- Receivables for Q1 2026 stood at $43004.0, down from $81571.0 in the prior quarter.
- The five-year high for Receivables was $350483.0 in Q3 2023, with the low at $35025.0 in Q3 2025.
- The 5-year median for Receivables is $103809.0 (2025), against an average of $172985.4.
- The sharpest annual moves came in 2024 and 2025: Receivables slumped 72.61% in 2024, then advanced 11.63% in 2025.
- Nexalin Technology's Receivables stood at $340875.0 in 2022, then sank by 71.05% to $98699.0 in 2023, then climbed by 3.72% to $102373.0 in 2024, then fell by 20.32% to $81571.0 in 2025, then slumped by 47.28% to $43004.0 in 2026.
- Business Quant data shows NXL's Receivables at $43004.0 in Q1 2026, $81571.0 in Q4 2025, and $35025.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 | 81,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81,000.00 |
| Mar 31, 2026 | 43,004.00 |
| Dec 31, 2025 | 81,571.00 |
| Sep 30, 2025 | 35,025.00 |
| Jun 30, 2025 | 104,171.00 |
| Mar 31, 2025 | 103,809.00 |
| Dec 31, 2024 | 102,373.00 |
| Sep 30, 2024 | 104,501.00 |
| Jun 30, 2024 | 101,050.00 |
| Mar 31, 2024 | 92,996.00 |
| Dec 31, 2023 | 98,699.00 |
| Sep 30, 2023 | 350,483.00 |
| Jun 30, 2023 | 350,322.00 |
| Mar 31, 2023 | 339,550.00 |
| Dec 31, 2022 | 340,875.00 |
| Sep 30, 2022 | 346,352.00 |
| Dec 31, 2021 | 352,303.00 |